Singular Genomics Systems, Inc.

NasdaqCM:OMIC Stock Report

Market Cap: US$50.6m

Singular Genomics Systems Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:OMIC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 24SellUS$554,269CRCM L.P.Company25,125US$23.49
04 Nov 24BuyUS$2,314,377CRCM L.P.Company140,974US$21.20
18 Sep 24BuyUS$1,806,220Tang Capital Management, LLCCompany122,416US$17.21
16 Sep 24BuyUS$2,437,662Tang Capital Management, LLCCompany249,584US$12.79

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OMIC?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms151,9226%
Hedge Funds166,1626.56%
Individual Insiders358,66814.2%
General Public823,27132.5%
Institutions1,033,72140.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 67.47% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.7%
Tang Capital Management, LLC
372,000US$7.4m0%0.54%
6.56%
Deerfield Management Company, L.P. Series C
166,162US$3.3m0%0.06%
6.14%
Eli Glezer
155,583US$3.1m0.81%no data
6%
Legend Capital Management Co., Ltd.
151,922US$3.0m0%0.2%
5.61%
Andrew Spaventa
142,203US$2.8m1.08%no data
5%
Arch Venture Partners, L.P.
126,630US$2.5m0%0.16%
4.97%
Domain Associates, L.L.C.
125,946US$2.5m-0.02%29.88%
3.3%
QVIDTVM Management LLC
83,558US$1.7m0%1.1%
3.08%
UBS Asset Management AG
77,984US$1.6m0%no data
2.79%
Impresa Management LLC
70,653US$1.4m0%1.04%
2.46%
The Vanguard Group, Inc.
62,418US$1.2m0%no data
2.01%
Perceptive Advisors LLC
50,896US$1.0m-28.2%0.02%
1.39%
David Barker
35,333US$705.2k0%no data
0.71%
Geode Capital Management, LLC
17,962US$358.5k7.11%no data
0.69%
HighTower Advisors, LLC
17,607US$351.4k0%no data
0.6%
BlackRock, Inc.
15,165US$302.7k-3.62%no data
0.46%
Michael Pellini
11,706US$233.6k-0.01%no data
0.42%
Tikvah Management LLC
10,561US$210.8k0%0.06%
0.38%
Dalen Meeter
9,502US$189.7k16%no data
0.13%
Jyotsna Ghai
3,283US$65.5k447%no data
0.025%
Bg Fund Management Luxembourg S.A.
623US$12.4k0%no data
0.022%
Samuel Ropp
558US$11.1k0%no data
0.02%
Kim Kamdar
500US$10.0k0%no data
0.016%
Barclays PLC Private Banking & Investment Banking Investment
409US$8.2k0%no data
0.015%
Bank of America Corporation, Asset Management Arm
369US$7.4k0.54%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 11:55
End of Day Share Price 2025/02/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Singular Genomics Systems, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael RyskinBofA Global Research
null nullEquisights
Matthew SykesGoldman Sachs